JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB259174

Human TANK (TRAF2) knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

TANK KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

View Alternative Names

I-TRAF, TANK_HUMAN, TRAF family member associated NFKB activator, TRAF family member-associated NF-kappa-B activator, TRAF interacting protein TANK isoform a, TRAF interacting protein TANK isoform b, TRAF-interacting protein

1 Images
Sanger Sequencing - Human TANK (TRAF2) knockout HeLa cell lysate (AB259174)
  • Sanger seq

Unknown

Sanger Sequencing - Human TANK (TRAF2) knockout HeLa cell lysate (AB259174)

Homozygous : Insertion of the selection cassette in exon 2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab259174-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human TANK knockout HeLa cell lysate", "number":"AB259174-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB259174-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TANK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TANK (TRAF family member-associated NF-kappa-B activator) and TRAF2 (TNF receptor-associated factor 2) are proteins involved in the regulation of immune responses. TANK also known as I-TRAF is a protein with a mass of approximately 49 kDa. TRAF2 has a mass of approximately 56 kDa. These proteins express in various immune cells including T and B lymphocytes. TANK interacts with TRAF2 to mediate downstream signaling pathways essential for immunity.
Biological function summary

The TANK/TRAF2 complex plays a role in modulating the NF-kappa-B signaling pathway which is important for inflammation and immune responses. This complex also contributes to cellular responses to stress and infection. TANK acts as an adaptor protein that interacts with TRAF2 to relay signals from upstream receptors ensuring proper immune function. Additionally TANK inhibits excessive activation of NF-kappa-B maintaining a balanced immune response.

Pathways

As it relates to regulating immune functions TANK/TRAF2 is pivotal in the NF-kappa-B and MAPK signaling pathways. In the NF-kappa-B pathway TRAF2 helps mediate the activation of downstream kinases which are critical for the translocation of NF-kappa-B to the nucleus. TANK works alongside other signaling molecules like TRAF3 and TRAF6 integrating signals that lead to gene transcription involved in immune response and cell survival.

The dysfunction of TANK/TRAF2 differs from normal regulatory controls it links to auto-inflammatory diseases and certain cancers. In autoimmune disorders such as systemic lupus erythematosus aberrant NF-kappa-B activity possibly influenced by TANK/TRAF2 leads to uncontrolled immune activation. In cancer particularly lymphomas altered TANK/TRAF2 signaling correlates with the unchecked proliferation of cells. The protein's interplay with receptor-interacting protein 1 (RIP1) further emphasizes its role as disruptions in this interaction are seen in pathological states.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com